Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,077 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The use of volunteers to implement electronic patient reported outcomes in lung cancer outpatient clinics.
Ala-Aldeen K, Stones N, Woolf D, Bayman N, Coote J, Harris M, Pemberton L, Sheikh H, Chan C, Hodgson C, Yorke J, Faivre-Finn C. Ala-Aldeen K, et al. Among authors: chan c. Tech Innov Patient Support Radiat Oncol. 2018 Jun 5;7:11-16. doi: 10.1016/j.tipsro.2018.05.002. eCollection 2018 Sep. Tech Innov Patient Support Radiat Oncol. 2018. PMID: 32095576 Free PMC article.
Palliative Lung Radiotherapy: Higher Dose Leads to Improved Survival?
Lewis TS, Kennedy JA, Price GJ, Mee T, Woolf DK, Bayman NA, Chan C, Coote JH, Faivre-Finn C, Harris MA, Hudson AM, Pemberton LS, Salem A, Sheikh HY, Mistry HB, Cobben DCP. Lewis TS, et al. Among authors: chan c. Clin Oncol (R Coll Radiol). 2020 Oct;32(10):674-684. doi: 10.1016/j.clon.2020.05.003. Epub 2020 Jun 26. Clin Oncol (R Coll Radiol). 2020. PMID: 32600918 Free PMC article. Clinical Trial.
Outcomes of curative-intent radiotherapy in non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD).
Tang C, Mistry H, Bayman N, Chan C, Cobben D, Faivre-Finn C, Harris M, Kennedy J, Pemberton L, Price G, Sheikh H, Woolf D, Coote J, Salem A. Tang C, et al. Among authors: chan c. Radiother Oncol. 2021 Jul;160:78-81. doi: 10.1016/j.radonc.2021.04.014. Epub 2021 Apr 24. Radiother Oncol. 2021. PMID: 33901563
Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer.
Fornacon-Wood I, Chan C, Bayman N, Banfill K, Coote J, Garbett A, Harris M, Hudson A, Kennedy J, Pemberton L, Salem A, Sheikh H, Whitehurst P, Woolf D, Price G, Faivre-Finn C. Fornacon-Wood I, et al. Among authors: chan c. Front Oncol. 2022 May 31;12:835844. doi: 10.3389/fonc.2022.835844. eCollection 2022. Front Oncol. 2022. PMID: 35712515 Free PMC article.
Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers.
Harrington KJ, Billingham LJ, Brunner TB, Burnet NG, Chan CS, Hoskin P, Mackay RI, Maughan TS, Macdougall J, McKenna WG, Nutting CM, Oliver A, Plummer R, Stratford IJ, Illidge T. Harrington KJ, et al. Among authors: chan cs. Br J Cancer. 2011 Aug 23;105(5):628-39. doi: 10.1038/bjc.2011.240. Epub 2011 Jul 19. Br J Cancer. 2011. PMID: 21772330 Free PMC article. Review. No abstract available.
Methodological considerations in the evaluation of radiotherapy technologies.
Burnet NG, Billingham LJ, Chan CS, Hall E, Macdougall J, Mackay RI, Maughan TS, Nutting CM, Staffurth JN, Illidge TM; National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Executive Group. Burnet NG, et al. Among authors: chan cs. Clin Oncol (R Coll Radiol). 2012 Dec;24(10):707-9. doi: 10.1016/j.clon.2012.06.003. Epub 2012 Jul 12. Clin Oncol (R Coll Radiol). 2012. PMID: 22795231 No abstract available.
12,077 results
You have reached the last available page of results. Please see the User Guide for more information.